UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014)

BMC public health, 2015-11, Vol.15 (1), p.1198-1198, Article 1198

Gandhi, Gian

2015

Volltextzugriff (PDF)

Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market

Vaccine: X, 2019-08, Vol.2, p.100033-100033, Article 100033

2019

Volltextzugriff (PDF)

Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations

BMC public health, 2015-11, Vol.15 (1)

Gandhi, Gian

2015

Volltextzugriff (PDF)

Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts

BMC public health, 2014-01, Vol.14 (1), p.67-67, Article 67

2014

Volltextzugriff (PDF)

Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011–2020

Vaccine, 2013-04, Vol.31, p.B137-B148

2013

Volltextzugriff (PDF)

Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011―2020: Decade of Vaccines

Vaccine, 2013, Vol.31

2013

Volltextzugriff (PDF)

Costs of bipolar disorder

PharmacoEconomics, 2003-01, Vol.21 (9), p.601-622

2003

Volltextzugriff (PDF)

Frequency of hospitalisations and inpatient care costs of manic episodes in patients with bipolar I disorder in France

PharmacoEconomics, 2003-01, Vol.21 (15), p.1081-1090

2003

Volltextzugriff (PDF)

Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older

Journal of clinical oncology, 2021-04, Vol.39 (11), p.1203-1213

2021

Volltextzugriff (PDF)

Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis

PloS one, 2010-05, Vol.5 (5), p.e10484-e10484

2010

Volltextzugriff (PDF)

Sinus node sparing novel hybrid approach for treatment of inappropriate sinus tachycardia/postural sinus tachycardia: multicenter experience

Journal of interventional cardiac electrophysiology, 2022-04, Vol.63 (3), p.531-544

2022

Volltextzugriff (PDF)

Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial

Journal of clinical oncology, 2024-05, Vol.42 (14), p.1612

2024

Volltextzugriff (PDF)

Subcutaneous rituximab induction followed by short rituximab maintenance to improve progression-free survival in patients with low-tumor burden follicular lymphoma: Final results of FLIRT phase III trial, a LYSA study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7512-7512

2022

Volltextzugriff (PDF)

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics

The World Allergy Organization journal, 2016, Vol.9 (10), p.10-10, Article 10

2016

Volltextzugriff (PDF)

Amnioreduction in cases of polyhydramnios: Indications and outcomes in singleton pregnancies without fetal interventions

European journal of obstetrics & gynecology and reproductive biology, 2019-10, Vol.241, p.126-128

2019

Volltextzugriff (PDF)

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Vitamin D

The World Allergy Organization journal, 2016, Vol.9 (16), p.17-17, Article 17

2016

Volltextzugriff (PDF)

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort

Blood advances, 2024-01, Vol.8 (2), p.296-308

2024

Volltextzugriff (PDF)

A Phase II Trial of Carboplatin and Weekly Topotecan in the First-Line Treatment of Patients with Extensive Stage Small Cell Lung Cancer

Journal of thoracic oncology, 2010-06, Vol.5 (6), p.862-866

2010

Volltextzugriff (PDF)

Pregnancy and Obesity

1, 2017

Volltextzugriff (PDF)

Weekly docetaxel and estramustine monophosphate (EMP) in the treatment of patients with prostate cancer and persistent/recurrent PSA elevation following primary therapy: A phase II trial of the Minnie Pearl Cancer Research Network

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4759-4759

2004

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

ThemaPublic Health

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Humans
(13)
Adult
(7)
Female
(7)
Life Sciences
(6)
Immunology
(5)
Male
(5)
Middle Aged
(5)
Aged
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Oncology
(4)
Analysis
(3)
Biological And Medical Sciences
(3)
Cyclophosphamide - Therapeutic Use
(3)
Doxorubicin - Therapeutic Use
(3)
Hematology
(3)
Immunization
(3)
Immunization Programs - Economics
(3)
Prednisone - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014)

Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market

Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations

Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts

Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011–2020

Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011―2020: Decade of Vaccines

Costs of bipolar disorder

Frequency of hospitalisations and inpatient care costs of manic episodes in patients with bipolar I disorder in France

Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older

Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study

Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis

Sinus node sparing novel hybrid approach for treatment of inappropriate sinus tachycardia/postural sinus tachycardia: multicenter experience

Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial

Subcutaneous rituximab induction followed by short rituximab maintenance to improve progression-free survival in patients with low-tumor burden follicular lymphoma: Final results of FLIRT phase III trial, a LYSA study

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics

Amnioreduction in cases of polyhydramnios: Indications and outcomes in singleton pregnancies without fetal interventions

Sub-Cutaneous Rituximab-Minichop Versus Sub-Cutaneous Rituximab-Minichop + Lenalidomide (R2-miniCHOP) in Diffuse Large B Cell Lymphoma for Patients of 80 Years Old or More (SENIOR Study). a Multicentric Randomized Phase III Study of the Lysa

Final Analysis of the Ro-CHOP Phase III Study (Conducted by LYSA): Romidepsin Plus CHOP in Patients with Peripheral T-Cell Lymphoma

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Vitamin D

Molecular Characterisation of Diffuse Large B Cell Lymphoma in Patients of 80 Years Old or More: Clinical Relevance in a Multicentric Randomized Phase III Study of the Lysa (SENIOR Study)

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort

A Phase II Trial of Carboplatin and Weekly Topotecan in the First-Line Treatment of Patients with Extensive Stage Small Cell Lung Cancer

Pregnancy and Obesity

Weekly docetaxel and estramustine monophosphate (EMP) in the treatment of patients with prostate cancer and persistent/recurrent PSA elevation following primary therapy: A phase II trial of the Minnie Pearl Cancer Research Network

Aktive Filter

Suchergebnisse filtern